Atlas Trials

Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705)

Clinical trial NCT00725725 · TERMINATED

Trial details

NCT number
NCT00725725
Sponsor
Merck Sharp & Dohme LLC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Panic Disorder
Start date
2008-07-23
Primary completion
2010-04-23
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.